Principal Financial Group
GSK icon

Principal Financial Group’s GSK GSK Stock Holding History

Principal Financial Group’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-4,800
Closed -$241K – 2269
2018
Q3 		$241K Sell
4,800
-3,200
-40% -$163K ﹤0.01% 2127
2018
Q2 		$403K Sell
8,000
-3,166
-28% -$159K ﹤0.01% 2010
2018
Q1 		$545K Hold
11,166
– – ﹤0.01% 1930
2017
Q4 		$495K Hold
11,166
– – ﹤0.01% 1962
2017
Q3 		$567K Hold
11,166
– – ﹤0.01% 1910
2017
Q2 		$602K Buy
+11,166
New +$595K ﹤0.01% 1915

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
BCIM
Black Creek Investment Management Toronto, Ontario, Canada $1.86B AUM 15.33% 1-Year Est. Return

Principal Financial Group's GSK Position: Q4 2018 in Review

Principal Financial Group sold out of GSK (GSK) in Q4 2018, closing a stake of 4,800 shares — an estimated $241K sold.

Principal Financial Group first reported a position in GSK in Q2 2017 and held it in 6 quarters. The position peaked at $602K in Q2 2017. 799 funds tracked by Wall St. Rank hold GSK as of Q4 2018.

  • Principal Financial Group reported no remaining GSK position as of Q4 2018 after selling out during the quarter.
  • Principal Financial Group sold 4,800 GSK shares in Q4 2018, an estimated $241K.
  • Principal Financial Group first reported a position in GSK in Q2 2017 and held it in 6 quarters.
  • Principal Financial Group's GSK position peaked at $602K in Q2 2017.
  • 799 funds tracked by Wall St. Rank held GSK as of Q4 2018.

Based on Principal Financial Group's 13F filing for Q4 2018, filed 14 Feb 2019.